HEALTHEURACTIV
Bulgaria’s ‘overregulated’ pharma market set for comprehensive reveiew [Advocacy Lab]
Bulgaria’s pharmaceutical market, described as 'overregulated,' is set for a comprehensive review by Advocacy Lab. The new government faces pressure to improve access to innovative therapies while addressing hospital debt.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
- STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
- STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
- STAT+: Hope for Kendall Square’s lab market
- STAT+: A political contest in the U.K. could shake up drug pricing